StockData
Altimmune, Inc. logo

Altimmune, Inc. (ALT) stock

ALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$1.53−0.03 (-1.92%)

Close on Nov 17, 2026Market cap $297.61MP/E –Yield –

Altimmune pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Altimmune's pe ratio was 0.2× on Jan 31, 2018.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2018Jan 31, 20180.2×−0.0
2017Dec 29, 20170.3×–

More Altimmune figures

See a number that looks wrong?